Ongoing and planned implementation studies for the lenacapavir as of October 2025. For product approvals, volumes, implementation, and price comparisons of long-acting PrEP, visit our dashboard on PrEPWatch.org.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!